RxDoctor Payments Data

David Adams, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · New York, NYNPI 1477506657

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (52.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Medtronic accounts for 80.0% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $21,834 and has fallen 97.9% since, to $451 in 2025.

$45,127in general payments, 2019–2025

Across 93 payments — averaging $485.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$36K
  • Edwards Lifesciences$5K
  • Abbott$3K
  • Artivion, Inc.$895
  • Vertex$61
  • Atricure, Inc.$15
$1,516,037in research payments, 2019–2025

Across 443 payments — averaging $3422.21 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$812K
  • Abbott$531K
  • Edwards Lifesciences$108K
  • Atricure, Inc.$65K

What the payments were for

  • Speaking & faculty fees$23,75053%
  • Travel & lodging$14,23632%
  • Food & beverage$7,09916%
  • Education$420%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)48$36,104
Edwards Lifesciences2$4,571
Abbott33$3,481
Artivion, Inc.8$895
Vertex1$61
Atricure, Inc.1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$45,127 in reported general payments places this provider in the 85th percentile of 383 thoracic surgery (cardiothoracic vascular surgery) providers in New York.

See all thoracic surgery (cardiothoracic vascular surgery) providers in New York

Medicare billing

Part B allowed, 2024
$498,641
Medicare patients
202
Services billed
513

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →